- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT01419301
Mindfulness Based Stress Reduction in Multiple Sclerosis (MS)
Mindfulness Based Stress Reduction in MS
This study focuses on stress, cognition, mood and fatigue and its effect on medication compliance. Medication compliance is measured by the weight of discarded needles. The investigators will be administering neuropsychological testing at baseline and the final visit. The subjects will complete self-report assessments during their 8 weeks in the study.
Group A will have additional weekly phone support for meditation, while Group B will have meditation training only.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
New York
-
Stony Brook, New York, Verenigde Staten, 11786-8121
- Stony Brook University
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Patients with either definite MS according to the revised McDonald criteria (Polman 2005) or patients with CIS (defined as an initial MS relapse with objective documentation and 2 or more lesions within the CNS of which at least one must involve the brain)
- Patients on GA therapy for at least 6 months
- Age 18 - 70
Exclusion Criteria:
- Unwilling to comply with study procedures
- Use of other DMT in conjunction with GA
- Unable to provide informed consent.
- Current (past 30 days) substance abuse
- Newly initiated (past 30 days) psychiatry treatment
- Enrolled in another program of meditation in the past six months.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Electronic measure of needle disposals (MEMS TrackCaps)
Tijdsspanne: Medication adherence will be measured by total number of missed doses, calculated from total needle disposals. The total number of missed doses across the six weeks will be compared between the two treatment groups at study end.
|
During the six-week MSBR program, medication adherence will be monitored with a widely used electronic measure of needle disposals (MEMS TrackCaps) This method has been demonstrated to be more accurate in MS than data obtained from either self-report or interview.
At one month intervals the patient will bring the needle container to the Study Coordinator.
All patients who attend at least introduction session and one telephone session will be included in the analysis.
|
Medication adherence will be measured by total number of missed doses, calculated from total needle disposals. The total number of missed doses across the six weeks will be compared between the two treatment groups at study end.
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Perceived Stress Scale-10
Tijdsspanne: Baseline, 1 X between weeks 3-7, Week 8
|
A 10-item scale of global perceived stress, where each item is rated from 1 to 5 according to intensity of stressor.
|
Baseline, 1 X between weeks 3-7, Week 8
|
Holmes and Rahe Social Readjustment Rating Scale (SRRS
Tijdsspanne: Baseline, 1 X between weeks 3-7, Week 8
|
Stressful life events will be rated using the SRRS, which asks subjects to check if they have experienced any of a series of life events.
We will use a modification of the scale used in previous MS research that eliminates several items specifically associated with MS disease activity (e.g., "major illness or injury", "sexual difficulties", "pregnancy").
The SRRS differentiates three types of stress: positive ("outstanding personal achievement"), major negative stress (death of family member), conflict and disruption in routine (e.g., family or job conflict, life changes).
|
Baseline, 1 X between weeks 3-7, Week 8
|
Chicago Multiscale Depression Inventory (CMDI)
Tijdsspanne: Baseline, 1 X betweeen Weeks 3-7, Week 8
|
CMDI is a self-report questionnaire designed specifically for use in MS and other medical patient groups.
It has vegetative, mood, and evaluative scales consisting of 14 items each.
The use of the CMDI makes it possible to separate out neurovegetative symptoms of depression which are a potential confound in medical populations such as MS
|
Baseline, 1 X betweeen Weeks 3-7, Week 8
|
State Trait Anxiety Inventory (STAI)
Tijdsspanne: Baseline, 1 X betweeen Weeks 3-7, Week 8
|
The STAI is a widely used measure of state and trait anxiety.
We will focus on the measurement of state related anxiety in this study.
|
Baseline, 1 X betweeen Weeks 3-7, Week 8
|
Positive and Negative Affect Scale (PANAS)
Tijdsspanne: Baseline, 1 X between Weeks 3 - 7, Week 8
|
; Watson, Clark & Tellegen, 1989): State related positive and negative affect will be assessed by the well validated PANAS scales.
|
Baseline, 1 X between Weeks 3 - 7, Week 8
|
Fatigue Severity Scale (FSS)
Tijdsspanne: Baseline, 1 X between Weeks 3 - 7, Week 8
|
The fatigue severity scale is a reliable and valid commonly used measure of the frequent symptom of fatigue in MS.
|
Baseline, 1 X between Weeks 3 - 7, Week 8
|
MACFIMS neuropsychological battery
Tijdsspanne: Baseline and Week 8
|
At baseline and study end, an abbreviated version of the MACFIMS will be administered.
This is a standard neurocognitive battery used with studies of MS subjects and includes the SDMT, PASAT, SRT, BVMT, and 9-hole peg test.
|
Baseline and Week 8
|
Expanded Disability Status Scale (EDSS)
Tijdsspanne: Baseline and Week 8
|
Expanded Disability Status Scale is the oldest and probably the most widely utilized assessment instruments in MS for determination of neurological impairment in MS.
It is the standard for characterization of MS patients and for outcomes of clinical trials.
It will be used to characterize patients' level of disability.
|
Baseline and Week 8
|
Physiologic Markers of Stress
Tijdsspanne: Baseline and Week 8
|
DHEA, epinephrine, and norepinephrine.
|
Baseline and Week 8
|
Physiologic Maker of Stress
Tijdsspanne: Baseline, 1 X between Week 3 - 7, Weeek 8
|
cortisol
|
Baseline, 1 X between Week 3 - 7, Weeek 8
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Lauren B Krupp, M.D., Stony Brook University
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- Teva186557-1
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Mindfulness based stress reduction (MBSR)
-
Amasya UniversityVoltooidOngerustheid | Zwangerschap gerelateerdKalkoen
-
Amasya UniversityVoltooidSpanning | Zwangerschap, hoog risicoKalkoen
-
Inonu UniversityVoltooidOngerustheid | Mindfulness | Werktevredenheid | Verloskundigen | Professionele burn-outKalkoen
-
University Hospital, BordeauxVoltooidZiekte van ParkinsonFrankrijk
-
Universidad Pontificia de SalamancaMinisterio de Ciencia e Innovación, SpainWervingOntstekingsreactie | Welzijn | Mentale gezondheid | Mindfulness | Cardiovasculaire gezondheid | ZelfcompassieSpanje
-
Amasya UniversityVoltooidOngerustheid | Zwangerschap gerelateerdKalkoen
-
Tel-Aviv Sourasky Medical CenterVoltooid
-
One FertilityActief, niet wervendKwaliteit van het leven | Geestelijke gezondheidskwestie | Primaire onvruchtbaarheidCanada
-
Universidad de GranadaChair in Conscience and Development (UGR); Mind, Brain and Behaviour Research...VoltooidOngerustheid | Psychische nood | Perfectionisme | Aandacht | Empathie | Creativiteit | Levensstress | Emotionele intelligentieSpanje
-
Instituto de Investigación Hospital Universitario...Universidad Autonoma de MadridVoltooid